Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Feb-23 7:35 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 701 | $103.83 | $72,784.50 | (2%) 43.04K to 42.34K | |
| 08-Feb-23 7:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 13,816 | $102.39 | $1,414,650.00 | (25%) 55.53K to 41.71K | |
| 08-Feb-23 7:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 801 | $105.82 | $84,758.10 | (3%) 30.1K to 29.3K | |
| 02-Feb-23 5:24 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 1,666 | $110.02 | $183,290.00 | (6%) 30.25K to 28.58K | |
| 16-Aug-22 6:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 15-Aug-22 | Option Exercise | 8,043 | $45.96 | $369,663.00 | 43% 18.89K to 26.93K | |
| 16-Aug-22 6:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Aug-22 | Option Exercise | 21,533 | $35.99 | $774,973.00 | 114% 18.89K to 40.42K | |
| 16-Aug-22 6:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Aug-22 | Planned Option Sale | 21,533 | $105.95 | $2,281,330.00 | (53%) 40.42K to 18.89K | |
| 09-Feb-22 7:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 701 | $79.53 | $55,750.60 | (4%) 19.43K to 18.73K | |
| 09-Feb-22 7:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 2,681 | $80.72 | $216,417.00 | (13%) 20.79K to 18.1K | |
| 29-Jul-21 5:32 PM View: | Neurocrine Biosciences Inc. (NBIX) | 27-Jul-21 | Market Sale (Planned) | 16,709 | $93.80 | $1,567,340.00 | (51%) 32.51K to 15.8K | (< 1%) |
| 12-Feb-21 8:27 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Feb-21 | Option Exercise | 1,700 | $35.99 | $61,183.00 | 5% 32.51K to 34.21K | |
| 12-Feb-21 8:27 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Feb-21 | Market Option Sale (Planned) | 1,700 | $119.96 | $203,926.00 | (5%) 34.21K to 32.51K | |
| 09-Feb-21 9:20 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-21 | Market Sale (Planned) | 3,261 | $116.81 | $380,929.00 | (9%) 35.77K to 32.51K | 1% |
| 09-Feb-21 9:20 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-21 | Market Sale (Planned) | 865 | $114.15 | $98,739.20 | (3%) 30.54K to 29.68K | (1%) |
| 27-Jan-21 9:30 PM View: | Neurocrine Biosciences Inc. (NBIX) | 26-Jan-21 | Option Exercise | 1,100 | $35.99 | $39,589.00 | 4% 29.0K to 30.1K | |
| 27-Jan-21 9:30 PM View: | Neurocrine Biosciences Inc. (NBIX) | 26-Jan-21 | Market Option Sale (Planned) | 1,100 | $119.97 | $131,965.00 | (4%) 30.1K to 29.0K | 4% |
| 27-Jan-21 9:30 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Jan-21 | Option Exercise | 17,570 | $34.46 | $605,470.00 | 61% 29.0K to 46.57K | |
| 27-Jan-21 9:30 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Jan-21 | Market Option Sale (Planned) | 17,570 | $119.97 | $2,107,810.00 | (38%) 46.57K to 29.0K | 4% |
| 16-Nov-20 6:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Nov-20 | Market Sale (Planned) | 2,257 | $90.73 | $204,776.00 | (7%) 31.26K to 29.0K | (27%) |
| 07-Aug-20 7:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-20 | Market Sale (Planned) | 2,257 | $118.86 | $268,277.00 | (8%) 29.23K to 26.97K | 3% |
| 28-Apr-20 8:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-20 | Market Sale (Planned) | 1,934 | $99.45 | $192,329.00 | (7%) 26.88K to 24.94K | (16%) |
| 11-Feb-20 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Feb-20 | Option Exercise | 28,969 | $59.65 | $1,728,150.00 | 125% 23.2K to 52.17K | |
| 11-Feb-20 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Feb-20 | Market Option Sale (Planned) | 27,954 | $104.56 | $2,922,950.00 | (54%) 52.17K to 24.21K | (11%) |
| 11-Feb-20 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Feb-20 | Market Sale (Planned) | 1,015 | $104.56 | $106,131.00 | (4%) 24.21K to 23.2K | (11%) |
| 11-Feb-20 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-20 | Market Option Sale (Planned) | 1,015 | $103.28 | $104,827.00 | (4%) 24.21K to 23.2K | (12%) |
| 07-Feb-20 6:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-20 | Market Sale (Planned) | 1,490 | $101.51 | $151,258.00 | (6%) 23.78K to 22.29K | (14%) |
| 07-Feb-20 6:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-20 | Market Sale (Planned) | 1,948 | $103.05 | $200,733.00 | (8%) 23.07K to 21.13K | (12%) |
| 16-Oct-19 4:20 PM View: | Neurocrine Biosciences Inc. (NBIX) | 14-Oct-19 | Option Exercise | 9,956 | $15.45 | $153,820.00 | 51% 19.61K to 29.57K | |
| 16-Oct-19 4:20 PM View: | Neurocrine Biosciences Inc. (NBIX) | 14-Oct-19 | Market Option Sale (Planned) | 9,956 | $90.85 | $904,487.00 | (34%) 29.57K to 19.61K | (27%) |
| 08-Feb-19 5:11 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-19 | Market Sale (Planned) | 920 | $83.58 | $76,893.80 | (5%) 20.16K to 19.24K | (38%) |
| 06-Feb-19 6:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-19 | Market Sale (Planned) | 1,272 | $88.14 | $112,119.00 | (7%) 18.78K to 17.51K | (31%) |
| 08-Nov-18 5:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Nov-18 | Option Exercise | 3,300 | $15.45 | $50,985.00 | 22% 15.32K to 18.62K | |
| 08-Nov-18 5:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Nov-18 | Market Option Sale (Planned) | 3,300 | $110.00 | $363,000.00 | (18%) 18.62K to 15.32K | (5%) |
| 08-Nov-18 5:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Nov-18 | Option Exercise | 5,700 | $15.45 | $88,065.00 | 37% 15.32K to 21.02K | |
| 08-Nov-18 5:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Nov-18 | Market Option Sale (Planned) | 5,700 | $110.02 | $627,096.00 | (27%) 21.02K to 15.32K | (5%) |
| 07-Feb-18 6:07 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-18 | Payment of Exercise | 1,314 | $82.48 | $108,379.00 | (8%) 16.63K to 15.32K | (40%) |
| 07-Feb-18 6:07 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-18 | Market Sale (Planned) | 960 | $83.19 | $79,862.60 | (6%) 14.94K to 13.98K | (39%) |
| 04-Jan-18 4:05 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Jan-18 | Option Exercise | 18,084 | $15.45 | $279,398.00 | 139% 13.02K to 31.1K | |
| 04-Jan-18 4:05 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Jan-18 | Market Option Sale (Planned) | 18,084 | $77.52 | $1,401,820.00 | (58%) 31.1K to 13.02K | (49%) |
| 23-May-17 4:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-May-17 | Option Exercise | 4,980 | $15.45 | $76,941.00 | 38% 13.02K to 18.0K | |
| 23-May-17 4:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-May-17 | Market Option Sale (Planned) | 4,980 | $54.00 | $268,920.00 | (28%) 18.0K to 13.02K | (114%) |
| 23-May-17 4:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 18-May-17 | Option Exercise | 4,980 | $15.45 | $76,941.00 | 38% 13.02K to 18.0K | |
| 23-May-17 4:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 18-May-17 | Market Option Sale (Planned) | 4,980 | $53.26 | $265,235.00 | (28%) 18.0K to 13.02K | (117%) |
| 13-Apr-17 4:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Apr-17 | Market Sale (Planned) | 13,065 | $50.42 | $658,774.00 | (50%) 26.08K to 13.02K | (129%) |
| 08-Feb-17 7:41 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-17 | Market Sale (Planned) | 116 | $44.61 | $5,174.76 | (10%) 1.2K to 1.08K | (159%) |
| 08-Feb-17 7:41 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-17 | Market Sale (Planned) | 727 | $43.15 | $31,370.10 | (100%) 0.73K to 0 | (168%) |
| 02-Sep-16 3:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Sep-16 | Option Exercise | 9,000 | $15.45 | $139,050.00 | 100% 0 to 9.0K | |
| 02-Sep-16 3:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Sep-16 | Market Option Sale (Planned) | 9,000 | $50.00 | $450,000.00 | (100%) 9.0K to 0 | (131%) |
| 02-Jun-16 4:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-May-16 | Option Exercise | 9,000 | $15.45 | $139,050.00 | 100% 0 to 9.0K | |
| 02-Jun-16 4:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-May-16 | Market Option Sale (Planned) | 9,000 | $50.00 | $450,000.00 | (100%) 9.0K to 0 | (131%) |